Rhenman & Partners Asset Management AB as of Dec. 31, 2022
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 93 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eli Lilly & Co. (LLY) | 3.4 | $32M | 88k | 365.84 | |
| AmerisourceBergen (COR) | 3.0 | $29M | 173k | 165.71 | |
| Medtronic SHS (MDT) | 2.8 | $27M | 350k | 77.72 | |
| Boston Scientific Corporation (BSX) | 2.8 | $27M | 585k | 46.27 | |
| Regeneron Pharmaceuticals (REGN) | 2.8 | $27M | 37k | 721.49 | |
| BioMarin Pharmaceutical (BMRN) | 2.7 | $26M | 254k | 103.49 | |
| Merck & Co (MRK) | 2.5 | $24M | 215k | 110.95 | |
| Gilead Sciences (GILD) | 2.4 | $23M | 270k | 85.85 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.4 | $23M | 80k | 288.78 | |
| Anthem (ELV) | 2.4 | $23M | 45k | 512.97 | |
| Tenet Healthcare Corp Com New (THC) | 2.4 | $23M | 471k | 48.79 | |
| Thermo Fisher Scientific (TMO) | 2.3 | $22M | 40k | 550.69 | |
| Hca Holdings (HCA) | 2.3 | $22M | 90k | 239.96 | |
| Becton, Dickinson and (BDX) | 2.2 | $21M | 83k | 254.30 | |
| Abbvie (ABBV) | 2.2 | $21M | 130k | 161.61 | |
| Cigna Corp (CI) | 2.1 | $21M | 62k | 331.34 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.1 | $20M | 128k | 159.31 | |
| UnitedHealth (UNH) | 2.1 | $20M | 38k | 530.18 | |
| Humana (HUM) | 2.1 | $20M | 39k | 512.19 | |
| Pfizer (PFE) | 1.9 | $18M | 350k | 51.24 | |
| Johnson & Johnson (JNJ) | 1.8 | $18M | 100k | 176.65 | |
| Alnylam Pharmaceuticals (ALNY) | 1.8 | $17M | 73k | 237.65 | |
| Biontech Se Sponsored Ads (BNTX) | 1.7 | $16M | 109k | 150.22 | |
| CVS Caremark Corporation (CVS) | 1.7 | $16M | 171k | 93.19 | |
| Cooper Cos Com New | 1.6 | $16M | 47k | 330.67 | |
| Inspire Med Sys (INSP) | 1.6 | $15M | 61k | 251.88 | |
| McKesson Corporation (MCK) | 1.5 | $15M | 39k | 375.12 | |
| Axonics Modulation Technolog (AXNX) | 1.5 | $14M | 230k | 62.53 | |
| Mirati Therapeutics | 1.4 | $14M | 300k | 45.31 | |
| Danaher Corporation (DHR) | 1.4 | $13M | 50k | 265.42 | |
| Harmony Biosciences Hldgs In (HRMY) | 1.4 | $13M | 240k | 55.10 | |
| Abbott Laboratories (ABT) | 1.3 | $13M | 117k | 109.79 | |
| Edwards Lifesciences (EW) | 1.1 | $11M | 144k | 74.61 | |
| Silk Road Medical Inc Common (SILK) | 1.1 | $10M | 196k | 52.85 | |
| Apellis Pharmaceuticals (APLS) | 1.1 | $10M | 200k | 51.71 | |
| Neurocrine Biosciences (NBIX) | 1.1 | $10M | 85k | 119.44 | |
| Cytokinetics Com New (CYTK) | 1.0 | $9.9M | 216k | 45.82 | |
| Shockwave Med (SWAV) | 1.0 | $9.7M | 47k | 205.61 | |
| Outset Med (OM) | 1.0 | $9.3M | 360k | 25.82 | |
| Iveric Bio | 1.0 | $9.2M | 430k | 21.41 | |
| Immunocore Hldgs Ads (IMCR) | 0.9 | $8.6M | 150k | 57.07 | |
| Insulet Corporation (PODD) | 0.9 | $8.5M | 29k | 294.39 | |
| Royalty Pharma Shs Class A (RPRX) | 0.9 | $8.5M | 215k | 39.52 | |
| Privia Health Group (PRVA) | 0.9 | $8.4M | 370k | 22.71 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.9 | $8.3M | 784k | 10.64 | |
| Biogen Idec (BIIB) | 0.9 | $8.3M | 30k | 276.92 | |
| Revance Therapeutics (RVNC) | 0.8 | $8.1M | 438k | 18.46 | |
| Xencor (XNCR) | 0.8 | $7.7M | 294k | 26.04 | |
| Bio-techne Corporation (TECH) | 0.8 | $7.5M | 90k | 82.88 | |
| ImmunoGen | 0.8 | $7.4M | 1.5M | 4.96 | |
| Natera (NTRA) | 0.7 | $6.6M | 165k | 40.17 | |
| Intra Cellular Therapies (ITCI) | 0.7 | $6.6M | 125k | 52.92 | |
| Karuna Therapeutics Ord | 0.6 | $5.9M | 30k | 196.50 | |
| West Pharmaceutical Services (WST) | 0.6 | $5.9M | 25k | 235.35 | |
| Esperion Therapeutics (ESPR) | 0.6 | $5.6M | 900k | 6.23 | |
| Veeva Sys Cl A Com (VEEV) | 0.6 | $5.6M | 35k | 161.38 | |
| Iovance Biotherapeutics (IOVA) | 0.6 | $5.5M | 864k | 6.39 | |
| Envista Hldgs Corp (NVST) | 0.6 | $5.5M | 164k | 33.67 | |
| EXACT Sciences Corporation (EXAS) | 0.6 | $5.4M | 110k | 49.51 | |
| Oak Street Health | 0.6 | $5.4M | 250k | 21.51 | |
| Seagen | 0.5 | $5.3M | 41k | 128.51 | |
| Olink Hldg Ab Sponsored Ads (OLK) | 0.5 | $4.9M | 194k | 25.38 | |
| Phreesia (PHR) | 0.5 | $4.9M | 150k | 32.36 | |
| Viewray (VRAYQ) | 0.5 | $4.5M | 1.0M | 4.48 | |
| R1 RCM (RCM) | 0.4 | $4.1M | 378k | 10.95 | |
| Agilon Health (AGL) | 0.4 | $4.1M | 255k | 16.14 | |
| Iqvia Holdings (IQV) | 0.4 | $4.1M | 20k | 204.89 | |
| Alkermes SHS (ALKS) | 0.4 | $3.9M | 150k | 26.13 | |
| Alignment Healthcare (ALHC) | 0.4 | $3.8M | 325k | 11.76 | |
| Glaukos (GKOS) | 0.4 | $3.7M | 85k | 43.68 | |
| Meiragtx Holdings (MGTX) | 0.4 | $3.6M | 555k | 6.52 | |
| Teladoc (TDOC) | 0.3 | $3.1M | 130k | 23.65 | |
| Relay Therapeutics (RLAY) | 0.3 | $3.0M | 200k | 14.94 | |
| Arvinas Ord (ARVN) | 0.3 | $2.9M | 85k | 34.21 | |
| 10x Genomics Cl A Com (TXG) | 0.3 | $2.7M | 75k | 36.44 | |
| Phathom Pharmaceuticals (PHAT) | 0.3 | $2.6M | 235k | 11.22 | |
| Sangamo Biosciences (SGMO) | 0.3 | $2.6M | 820k | 3.14 | |
| Novocure Ord Shs (NVCR) | 0.3 | $2.6M | 35k | 73.35 | |
| Nuvalent Inc-a (NUVL) | 0.2 | $2.4M | 80k | 29.78 | |
| Mersana Therapeutics (MRSN) | 0.2 | $2.3M | 400k | 5.86 | |
| Allogene Therapeutics (ALLO) | 0.2 | $2.1M | 340k | 6.29 | |
| G1 Therapeutics (GTHX) | 0.2 | $2.0M | 370k | 5.43 | |
| Health Catalyst (HCAT) | 0.2 | $1.9M | 180k | 10.63 | |
| Ionis Pharmaceuticals (IONS) | 0.2 | $1.9M | 50k | 37.77 | |
| Rigel Pharmaceuticals Com New (RIGL) | 0.2 | $1.8M | 1.2M | 1.50 | |
| Intellia Therapeutics (NTLA) | 0.2 | $1.7M | 50k | 34.89 | |
| Stereotaxis Com New (STXS) | 0.2 | $1.7M | 797k | 2.07 | |
| Intuitive Surgical Com New (ISRG) | 0.1 | $1.3M | 5.0k | 265.35 | |
| Nektar Therapeutics (NKTR) | 0.1 | $1.2M | 550k | 2.26 | |
| Nkarta (NKTX) | 0.1 | $1.2M | 200k | 5.99 | |
| Essa Pharma Com New (EPIX) | 0.1 | $945k | 375k | 2.52 | |
| Igm Biosciences (IGMS) | 0.1 | $851k | 50k | 17.01 | |
| Rapid Micro Biosystems Class A Com (RPID) | 0.0 | $339k | 300k | 1.13 |
